National Bank of Canada

National Bank of Canada’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

National Bank of Canada’s Portfolio MRTX Stock Details MRTX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell
2023 Q4	$28M	Buy
2023 Q3	–	Sell
2023 Q2	$3.39M	Sell
2023 Q1	$12.7M	Sell
2022 Q4	$16.6M	Buy
2022 Q3	$17.6M	Sell
2022 Q2	$33.5M	Buy
2022 Q1	$12K	Sell
2021 Q4	$7.21M	Buy